學門類別
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- A practical guide to SEC ï¬nancial reporting and disclosures for successful regulatory crowdfunding
- Quality shareholders versus transient investors: The alarming case of product recalls
- The Health Equity Accelerator at Boston Medical Center
- Monosha Biotech: Growth Challenges of a Social Enterprise Brand
- Assessing the Value of Unifying and De-duplicating Customer Data, Spreadsheet Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise, Data Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise
- Board Director Dilemmas: The Tradeoffs of Board Selection
- Barbie: Reviving a Cultural Icon at Mattel (Abridged)
- Happiness Capital: A Hundred-Year-Old Family Business's Quest to Create Happiness
Ethena: A Go-to-Market Dilemma
內容大綱
In November 2021, Roxanne Petraeus and Anne Solmssen, founders of Brooklyn-based software-as-a-service (SaaS) startup Ethena, were looking to expand their compliance training business. The founders hired Arnie Gullov-Singh, an outside revenue consultant, to advise on whether to pursue mid-market sales or enterprise sales as the company scaled. Gullov-Singh performed a diagnostic of Ethena's sales funnel and found mid-market to be a reliable, growth-oriented trajectory for the company. The data for enterprise, however, was more limited, making it harder to recommend pursuing with confidence. Petraeus felt enterprise was attainable, nonetheless, especially given Ethena's client base already included some high-profile enterprise firms. Together with Vice President of Customer Success Akhila Iruku, the group discussed whether pursuing both mid- market and enterprise was feasible, and in light of the limited data on enterprise, whether it was wise. Ethena: A Go-to-Market Dilemma (HBS No. 723-363) also includes supplements: Ethena: Pre-Seed Pitch Deck Supplement 1 (HBS No. 723-385); Ethena: Seed Pitch Deck Supplement 2 (HBS No. 723-386); and Ethena: Series A Pitch Deck Supplement 3 (HBS No. 723-387).